RMTI
Rockwell Medical IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$31.30M
P/E Ratio
—
EPS
$-0.15
Beta
1.66
52W High
$2.10
52W Low
$0.74
50-Day MA
$0.90
200-Day MA
$1.05
Dividend Yield
—
Profit Margin
-7.99%
Forward P/E
59.17
PEG Ratio
4.43
About Rockwell Medical Inc
Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.
Fundamentals
| Revenue (TTM) | $67.68M |
| Gross Profit (TTM) | $11.55M |
| EBITDA | $-2.61M |
| Operating Margin | -8.54% |
| Return on Equity | -15.30% |
| Return on Assets | -5.04% |
| Revenue/Share (TTM) | $1.81 |
| Book Value | $0.94 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | 0.47 |
| EV/Revenue | 0.33 |
| EV/EBITDA | 30.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -8.30% |
| Shares Outstanding | $39.47M |
| Float | $35.20M |
| % Insiders | 12.25% |
| % Institutions | 10.13% |
Historical Volatility
HV 10-Day
35.30%
HV 20-Day
50.45%
HV 30-Day
48.82%
HV 60-Day
55.43%
HV Rank
6.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($3.00 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026